Content about Sun Pharmaceutical

February 8, 2013

Taro, Sun slam brakes on acquisition deal

Israeli drug maker Taro Pharmaceutical Industries and Indian drug maker Sun Pharmaceutical Industries have terminated their merger agreement, the companies said in a joint statement Friday.

December 17, 2012

Takeda to sell URL Pharma to Caraco Pharmaceutical Labs

Japanese drug maker Takeda Pharmaceutical Co. is selling its generics business to India-based Sun Pharmaceutical Industries, Takeda said.

September 18, 2012

Mergers among generics cos. on the rise

Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry. 

August 28, 2012

Sun Pharma's Caraco gets FDA OK to resume operations

The Food and Drug Administration has determined that generic drug maker Caraco is in compliance with relevant paragraphs of the consent decree and may resume operations at its manufacturing facility and packaging sites in Detriot and Wixom, Mich., Caraco's parent company Sun Pharmaceutical Industries said.

August 13, 2012

Sun to take Taro private

Sun Pharmaceutical Industries will take Taro Pharmaceutical Industries private, under a merger agreement between the two companies announced Sunday.

July 19, 2012

Taro board rejects Sun acquisition offer

Israeli drug maker Taro Pharmaceutical Industries has rejected India-based Sun Pharmaceutical Industries' takeover bid, Taro said Thursday.

May 29, 2012

Sun appoints former Teva CEO as chairman

Generic drug maker Sun Pharmaceutical Industries appointed a new chairman as the company announced big jumps in fourth-quarter and fiscal year 2012 sales and profits.

April 25, 2012

Sun launches generic version of Zyprexa

Sun Pharmaceutical Industries has launched a generic version of a drug used to treat psychiatric disorders, the company said.

January 17, 2012

Taro committee continues to evaluate Sun offer, Taro says

A committee formed by Taro Pharmaceutical Industries in December is continuing to evaluate an acquisition offer by India-based Sun Pharmaceutical Industries, Taro said.

December 12, 2011

FDA approves painkiller made by Sun Pharmaceutical Industries

The Food and Drug Administration has approved a generic painkiller made by Sun Pharmaceutical Industries, Sun said.

December 6, 2011

Taro forms special committee to review Sun offer

Israel's Taro Pharmaceutical Industries has formed a special committee to review an offer by India's Sun Pharmaceutical Industries for all of the issues of Taro that Sun doesn't already own, Taro said.

October 4, 2011

Sun Pharma resolves FDA warning letter

Sun Pharmaceutical Industries last month said that it has resolved issues cited in a warning letter sent to the company by the Food and Drug Administration pertaining to one of Sun Pharma's U.S.-based manufacturing facilities.

August 18, 2011

Sun Pharma receives FDA OK for finasteride

Generic drug maker Sun Pharmaceutical Industries has received regulatory approval for a drug designed to treat an enlarged prostate.

June 6, 2011

12 generic versions of Femara in market, FDA reports

The Food and Drug Administration has approved a dozen new generic versions of a drug used to treat breast cancer, the agency said Monday.

February 23, 2011

Caraco, Sun to merge

Generic drug maker Caraco Pharmaceutical Industries will merge with Sun Pharmaceutical Industries, Caraco said Tuesday.

February 18, 2011

ReportersNotebook — Chain Pharmacy, 2/28/11

SUPPLIER NEWS — Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores. Valeant acquired the rights to nonophthalmic topical formulations of Zovirax (acyclovir) from GSK for $300 million through its Canadian subsidiary, Biovail Labs.  

September 28, 2010

Subsequent offering period expires for Sun Pharma

Sun Pharmaceutical Industries' subsequent offering period by one of its subsidiaries for all outstanding ordinary...

March 11, 2010

Caraco launches colon, rectal cancer generic

Caraco Pharmaceutical Labs has launched a generic version of a drug for treating colon and...

January 4, 2010

Taro elects directors in shareholders meeting; Sun disapproves

An Israeli drug maker said that its shareholders voted to elect all of the directors...